Global X Genomics & Biotechnology ETF
GNOM
GNOM
26 hedge funds and large institutions have $59.9M invested in Global X Genomics & Biotechnology ETF in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.81% less ownership
Funds ownership: 15.57% → 13.76% (-1.8%)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.65M | |
| 2 | +$2.38M | |
| 3 | +$1.82M | |
| 4 |
Jane Street
New York
|
+$1.37M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$509K |
Top Sellers
| 1 | -$310K | |
| 2 | -$38.7K | |
| 3 | -$19.2K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$18.7K |
| 5 |
AA
Advisory Alpha
Holland,
Michigan
|
-$18K |